Pancreatic Adenosquamous Carcinoma — Trials

Pancreatic Adenosquamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04896073	Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)	completed	Phase 2	16	National Cancer Institute (NCI)NIH	1	Aug 14, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 14, 2026source: clinicaltrials